glp 1 receptor signaling pathway GLP-1 and Oral Dysfunction: A Narrative Review on the Mechanistic Basis of Semaglutide-Related Oral Adverse Effects The therapeutic potential of GLP‐1

This guide explains how semaglutide functions in thyroidectomy patients and what you need to know about GLP-1 therapy when living without a thyroid

Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases

| Novo Nordisk and Hims & Hers struck a truce after sparring over compounded versions of the pharma giant's branded GLP-1 drugs

Noom is offering 'microdoses' of semaglutide at a knock-down price, claiming they can prevent side effects, but remain effective for weight loss.

its effects on cardiovascular outcomes in people with type 2 diabetes, as well as on reducing morbidity and mortality in people with obesity/overweight, remain under investigation